Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001214659-24-011873

Director acquired 341 shares (code L)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Young Caroline · Director

Table I: Non-derivative

11 lines
Date Transaction Shares Price Value Owned after D/I
2024-06-13 Other acquisition : show line 1 in the form 10b5-1 +25 $1.52 $38 26,726 D
2024-06-14 Other acquisition : show line 2 in the form 10b5-1 +48 $1.50 $72 26,774 D
2024-06-17 Other acquisition : show line 3 in the form 10b5-1 +41 $1.49 $61 26,815 D
2024-06-18 Other acquisition : show line 4 in the form 10b5-1 +41 $1.57 $64 26,856 D
2024-06-20 Other acquisition : show line 5 in the form 10b5-1 +41 $1.53 $63 26,897 D
2024-06-21 Other acquisition : show line 6 in the form 10b5-1 +41 $1.49 $61 26,938 D
2024-06-24 Other acquisition : show line 7 in the form 10b5-1 +21 $1.59 $33 26,959 D
2024-06-25 Other acquisition : show line 8 in the form 10b5-1 +21 $1.54 $32 26,980 D
Loading xslF345X05/marketforms-66487.xml…